<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Cheminform</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Cheminform</journal-id>
    <journal-title-group>
      <journal-title>Journal of Cheminformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-2946</issn>
    <publisher>
      <publisher-name>Springer International Publishing</publisher-name>
      <publisher-loc>Cham</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8097257</article-id>
    <article-id pub-id-type="publisher-id">514</article-id>
    <article-id pub-id-type="doi">10.1186/s13321-021-00514-2</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>SANCDB: an update on South African natural compounds and their readily available analogs</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Diallo</surname>
          <given-names>Bakary N’tji</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Glenister</surname>
          <given-names>Michael</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Musyoka</surname>
          <given-names>Thommas M.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lobb</surname>
          <given-names>Kevin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6861-7849</contrib-id>
        <name>
          <surname>Tastan Bishop</surname>
          <given-names>Özlem</given-names>
        </name>
        <address>
          <email>O.tastanbishop@ru.ac.za</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.91354.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2364 1300</institution-id><institution>Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, </institution><institution>Rhodes University, </institution></institution-wrap>Makhanda/Grahamstown, 6140 South Africa </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.91354.3a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2364 1300</institution-id><institution>Department of Chemistry, </institution><institution>Rhodes University, </institution></institution-wrap>Makhanda/Grahamstown, 6140 South Africa </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>5</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>5</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>13</volume>
    <elocation-id>37</elocation-id>
    <history>
      <date date-type="received">
        <day>21</day>
        <month>11</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>4</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">South African Natural Compounds Database (SANCDB; <ext-link ext-link-type="uri" xlink:href="https://sancdb.rubi.ru.ac.za/">https://sancdb.rubi.ru.ac.za/</ext-link>) is the sole and a fully referenced database of natural chemical compounds of South African biodiversity. It is freely available, and since its inception in 2015, the database has become an important resource to several studies. Its content has been: used as training data for machine learning models; incorporated to larger databases; and utilized in drug discovery studies for hit identifications.</p>
      </sec>
      <sec>
        <title>Description</title>
        <p id="Par2">Here, we report the updated version of SANCDB. The new version includes 412 additional compounds that have been reported since 2015, giving a total of 1012 compounds in the database. Further, although natural products (NPs) are an important source of unique scaffolds, they have a major drawback due to their complex structure resulting in low synthetic feasibility in the laboratory. With this in mind, SANCDB is, now, updated to provide direct links to commercially available analogs from two major chemical databases namely Mcule and MolPort. To our knowledge, this feature is not available in other NP databases. Additionally, for easier access to information by users, the database and website interface were updated. The compounds are now downloadable in many different chemical formats.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">The drug discovery process relies heavily on NPs due to their unique chemical organization. This has inspired the establishment of numerous NP chemical databases. With the emergence of newer chemoinformatic technologies, existing chemical databases require constant updates to facilitate information accessibility and integration by users. Besides increasing the NPs compound content, the updated SANCDB allows users to access the individual compounds (if available) or their analogs from commercial databases seamlessly.</p>
      </sec>
      <sec>
        <title>Graphic abstract</title>
        <p id="Par100">
          <graphic position="anchor" xlink:href="13321_2021_514_Figa_HTML" id="MO9"/>
        </p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13321-021-00514-2.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>SANCDB</kwd>
      <kwd>Natural products</kwd>
      <kwd>Commercial analogs</kwd>
      <kwd>Drug discovery</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>DELGEME - Wellcome Trust</institution>
        </funding-source>
        <award-id>107740/Z/15/Z</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Grand Challenges Africa programme</institution>
        </funding-source>
        <award-id>GCA/DD/rnd3/023</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Özlem</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>H3ABioNet - NIH</institution>
        </funding-source>
        <award-id>U24HG006941</award-id>
        <principal-award-recipient>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Özlem</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par28">Throughout history, natural products (NPs) have benefited mankind in food, pesticides, cosmetic products and as drugs [<xref ref-type="bibr" rid="CR1">1</xref>]. NP research has, especially, been a growing field in modern drug discovery as they offer unique chemical scaffolds [<xref ref-type="bibr" rid="CR2">2</xref>], hence a greater structural diversity than synthetic ones, and they cover a large area of chemical space [<xref ref-type="bibr" rid="CR3">3</xref>]. Between 2010 and 2019, NPs contributed to 25–33% of approved small molecules [<xref ref-type="bibr" rid="CR4">4</xref>], and it is estimated that they represent 35% of medicines [<xref ref-type="bibr" rid="CR5">5</xref>]. Some of the notable approved drugs, either from pure or derived NPs, include lefamulin, the aminoglycoside antibiotic plazomicin; tafenoquine succinate, an antimalarial agent; and aplidine, an anticancer agent [<xref ref-type="bibr" rid="CR4">4</xref>]. Given the high interest in NP research, over 120 NP databases and collections have been developed, and are continuously being updated [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] with new information and functionalities.</p>
    <p id="Par29">The South African Natural Compounds Database (SANCDB; <ext-link ext-link-type="uri" xlink:href="https://sancdb.rubi.ru.ac.za/">https://sancdb.rubi.ru.ac.za/</ext-link>) is a fully referenced database of NPs derived from sources within South Africa [<xref ref-type="bibr" rid="CR6">6</xref>]. The database and website were established by the Research Unit in Bioinformatics (RUBi) in 2015. The main content of the database is a set of NP chemical structures in different chemical formats linked to their primary literature reference. Since its creation, the database has attracted significant interest in diverse domains including NP research, drug discovery, cheminformatics and machine learning with up to 52 citations. Besides its use in hit identification in drug discovery studies, SANCDB content has also served as training data for machine learning models [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]; training data for a NPs likeness scorer (NaPLeS) [<xref ref-type="bibr" rid="CR7">7</xref>]; and for NP-Scout, a machine learning approach for the identification of NPs [<xref ref-type="bibr" rid="CR9">9</xref>]. Similarly, the database compounds have served to train STarFish, a target fishing model for NPs [<xref ref-type="bibr" rid="CR8">8</xref>]. SANCDB was also utilized as an intermediate node for data integration into larger or more specialized information systems. An example is Natural Product Activity and Species Source (NPASS), which is a NP activity and species source database built on some NPs data resources, including SANCDB [<xref ref-type="bibr" rid="CR10">10</xref>]. Similarly, SANCDB data has also been used in the COCONUT (COlleCtion of Open Natural ProdUcTs) database [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
    <p id="Par30">The usage of the South African natural compounds as drugs is yet to be reported. However, the search for potential hits with activity against infectious agents and cancer is on the rise, and may lead to the identification of drugs in the near future [<xref ref-type="bibr" rid="CR12">12</xref>]. In terms of drug discovery studies, the database has been used for identification of hit compounds against the active (orthosteric) site of various biological drug targets in diseases including malaria, trypanosomiasis and severe acute respiratory syndrome Corona Virus 2 (SARS-COV-2) [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Additionally, potential allosteric modulators such as 20(29)-lupene-3β-isoferulate (SANC00518) for human Hsp90α [<xref ref-type="bibr" rid="CR14">14</xref>]; discorhabdin N (SANC00132), for human Hsp72 and Hsc70 [<xref ref-type="bibr" rid="CR15">15</xref>]; gordonoside A (SANC00456) for <italic>Plasmodium falciparum</italic> Prolyl tRNA synthetase [<xref ref-type="bibr" rid="CR19">19</xref>] have also been identified from SANCDB.</p>
    <p id="Par31">Here, we present an updated version of SANCDB with a number of new features. Firstly, over the last five years, since the inception of SANCDB, considerable NP research has been performed in the country. For instance, in 2019, Fantoukh et al. isolated 11 compounds from <italic>Aspalathus linearis</italic> [<xref ref-type="bibr" rid="CR20">20</xref>], and Awolola et al. reported four compounds from the genus <italic>Ficus</italic> [<xref ref-type="bibr" rid="CR21">21</xref>]. A variety of flavonoids, proanthocyanidins, ellagitannins, oligosaccharides and quinic acid derivatives were isolated from <italic>Myrothamnus flabellifolia Welw</italic> in 2016 [<xref ref-type="bibr" rid="CR22">22</xref>]. Thus, the updated SANCDB has curated such continuously growing information. Secondly, in the updated version of the database, we provide links to commercially available analogs for each compound to increase the search space and the availability of physical compounds. We hope that this unique feature of SANCDB will later be implemented by other NPs databases. Most of the time NPs’ physical availability is either limited [<xref ref-type="bibr" rid="CR1">1</xref>] or very expensive due to required isolation methods [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]; and it has been well demonstrated that they can serve as good start points for the development of synthesizable analogs which may lead to effective drugs [<xref ref-type="bibr" rid="CR24">24</xref>]. Finally, we include a scaffold analysis for all compound entries; this was undertaken to determine the database chemical diversity, which is an important aspect in the exploration of potential hit compounds [<xref ref-type="bibr" rid="CR25">25</xref>]. Compound classification in SANCDB is also revisited.</p>
  </sec>
  <sec id="Sec2">
    <title>Methods</title>
    <sec id="Sec3">
      <title>Update of the database</title>
      <p id="Par32">NPs isolated from South African sources were searched in the literature, and uploaded through the earlier pipeline described in the preceding publication [<xref ref-type="bibr" rid="CR6">6</xref>]. Elsevier's abstract and citation database (Scopus) Application Programming Interface (API) was used to identify more references. This allowed access to the scholarly databases indexed by Scopus [<xref ref-type="bibr" rid="CR26">26</xref>] for collection, parsing and extraction of organized literature references. From the current set of references in SANCDB, we retrieved the list of all authors using the reference Digital Object Identifier (DOI). Using the Scopus API [<xref ref-type="bibr" rid="CR26">26</xref>], a list of all publications associated with each author was retrieved. Both redundant publications and those in which none of the authors had a South African affiliation were removed as a pre-filtering step. From the remaining list of publications, the abstracts, and if available, the full text of the articles, were retrieved. Keywords “South Africa”, “compound” and “isolate” were then searched in the abstracts and full texts, removing documents not presenting any of these keywords. The resulting list of publications was then searched in SciFinder [<xref ref-type="bibr" rid="CR27">27</xref>] to find each compound’s Chemical Abstracts Service (CAS) [<xref ref-type="bibr" rid="CR27">27</xref>] number. References were then checked to confirm that sources were indeed from South Africa. Using an updated pipeline described in the original publication [<xref ref-type="bibr" rid="CR6">6</xref>], new compounds were uploaded into the database. Compound sources were mapped to their genera, families and kingdoms using pygbif [<xref ref-type="bibr" rid="CR28">28</xref>] a Python client for the Global Biodiversity Information Facility (GBIF) [<xref ref-type="bibr" rid="CR29">29</xref>] API. PubChemPy [<xref ref-type="bibr" rid="CR30">30</xref>] was used to retrieve additional information on chemical compounds utilizing their CAS number as query. Compound IDs for different databases (ChEMBL [<xref ref-type="bibr" rid="CR31">31</xref>], DrugBank [<xref ref-type="bibr" rid="CR32">32</xref>], ZINC [<xref ref-type="bibr" rid="CR33">33</xref>], PubChem [<xref ref-type="bibr" rid="CR34">34</xref>]) were automatically retrieved from PubChem [<xref ref-type="bibr" rid="CR34">34</xref>]. Besides the previously assigned compound classification generated manually, additional automated classification based on ClassyFire [<xref ref-type="bibr" rid="CR35">35</xref>] was also included. To allow diverse usage of the compounds in docking studies, structures were prepared in different ready-to-dock formats, viz AutoDock <italic>pdbqt</italic> and Schrödinger Maestro format [<xref ref-type="bibr" rid="CR36">36</xref>]. All aromatic compound structure depictions were standardized to the Kekulé form.</p>
    </sec>
    <sec id="Sec4">
      <title>Analogs</title>
      <p id="Par33">Analogs for each SANCDB entry were extracted from the Mcule [<xref ref-type="bibr" rid="CR37">37</xref>] and Molport [<xref ref-type="bibr" rid="CR38">38</xref>] databases. The set of purchasable compounds in SMILES format from each of these databases (Version October 2019, latest version at that date) was downloaded. Similarity scores (Tanimoto coefficient) were computed using OpenBabel (Version 2.3) [<xref ref-type="bibr" rid="CR39">39</xref>] fingerprint FP2 [<xref ref-type="bibr" rid="CR40">40</xref>], a path-based fingerprint which indexes compounds linear fragments up to seven atoms. With the set of indexed fragments, a hash number from zero to 1020 was used to set a bit in a 1024-bit vector. A Tanimoto coefficient of 0.6 or greater was used as cut-off for analog identification. These steps have been incorporated into an automated update pipeline in the backend which fetches updated analog data from the respective Mcule and MolPort database APIs monthly. The front end of the database has also received updates and additions to integrate information about the newly added compounds and analogs.</p>
    </sec>
    <sec id="Sec5">
      <title>Chemoinformatic analysis</title>
      <p id="Par34">SANCDB compounds’ scaffolds were calculated through the Bemis-Murcko decomposition of molecules [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. Scopy [<xref ref-type="bibr" rid="CR46">46</xref>] was utilized for scaffold calculations. Unique scaffolds from each molecule were assembled with their respective frequencies to generate the molecule cloud [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>].</p>
      <p id="Par35">An analysis of compound distributions into drug-like, extended drug-like, lead-like, fragment-like, protein–protein inhibitor-like (PPI-like) subsets was performed (Table <xref rid="Tab1" ref-type="table">1</xref>), using conditions defined previously [<xref ref-type="bibr" rid="CR48">48</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Molecular properties and conditions used to determine compound subsets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Molecular properties</th><th align="left">Conditions</th></tr></thead><tbody><tr><td align="left">Drug-like</td><td align="left">MW ≤ 500 &amp; MW ≥ 150 &amp; logP ≤ 5 &amp; nHD ≤ 5 &amp; nHA ≤ 10</td></tr><tr><td align="left">Extended drug-like</td><td align="left">Druglike &amp; nRot ≤ 7 &amp; TPSA &lt; 150</td></tr><tr><td align="left">Lead-like</td><td align="left">MW ≥ 250 &amp; MW ≤ 350 &amp; nRot ≤ 7 &amp; logP ≤ 3.5</td></tr><tr><td align="left">Fragment-like</td><td align="left">nHA ≥ 3 &amp; MW ≤ 300 &amp; nHD ≤ 3 &amp; logP ≤ 3</td></tr><tr><td align="left">PPI-like</td><td align="left">nRing ≥ 4 &amp; MW &gt; 400 &amp; nHA &gt; 4 &amp; logP &gt; 4</td></tr></tbody></table><table-wrap-foot><p><italic>MW</italic>  Molecular weight, <italic>logP</italic> lipophilicity, <italic>nHA</italic>  number of hydrogen bond acceptor, <italic>nHD</italic>  number of hydrogen bond donor, <italic>TPSA</italic>  total polar surface area, <italic>nRot</italic> number of rotatable bonds and <italic>nRing</italic> number of rings</p></table-wrap-foot></table-wrap></p>
      <p id="Par36">To assess the coverage of SANCDB chemical space by the analogs, Principal Component Analysis (PCA) and t-Distributed Stochastic Neighbor Embedding (t-SNE) were applied on compounds’ non-normalized Molecular Quantum Numbers (MQN) [<xref ref-type="bibr" rid="CR49">49</xref>] for dimensionality reduction. MQN descriptors were computed using rdkit.Chem.rdMolDescriptors module of RDKit [<xref ref-type="bibr" rid="CR50">50</xref>]. T-SNE is a variant of Stochastic Neighbor Embedding calculating similarity between two points in the low-dimensional space using a Student-t distribution [<xref ref-type="bibr" rid="CR51">51</xref>]. The method has been used for chemical space analysis [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]. PCA and t-SNE implementations in scikit-learn were used [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. A learning rate of 100 and perplexity of 50 were used for t-SNE. Other parameters were kept to default. The 42 dimensions in MQN property space were reduced to two dimensions with both methods. The 3D structures of the identified analogs were prepared using OpenBabel [<xref ref-type="bibr" rid="CR39">39</xref>] and resulting geometries minimized in RDKit [<xref ref-type="bibr" rid="CR50">50</xref>] using the Merck Molecular Force Field (MMFF94) [<xref ref-type="bibr" rid="CR57">57</xref>]. Moreover, the AutoDock ready to dock files ‘<italic>pdbqt</italic>’ were prepared using AutoDock 4 utilities [<xref ref-type="bibr" rid="CR58">58</xref>]. The data was analyzed in the Jupyter Notebook [<xref ref-type="bibr" rid="CR59">59</xref>] environment using the Python module pandas [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>] and pandas-profiling [<xref ref-type="bibr" rid="CR62">62</xref>]. The descriptive statistics and plots were done in the same environment.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results and discussions</title>
    <sec id="Sec7">
      <title>Database design and website interface</title>
      <p id="Par37">SANCDB uses a MySQL database, managed by the Django framework as described previously [<xref ref-type="bibr" rid="CR6">6</xref>]. The appearance of the site has seen numerous minor changes such as removing clutter from page elements and menus, using Bootstrap to standardize elements, and adjusting text sizes to give the site a more modern and neater appearance. Redundant and unused JavaScript and CSS libraries have been removed. This reduced the initial page load by 0.5 MB and improved maintainability of the SANCDB codebase.</p>
      <p id="Par38">A similarity search was added to the database search functionalities. The database originally only had a substructure search function. The user can now do a similarity or a substructure search. The query is searched in the database using Open Babel FP2 fingerprints and all compounds having at least 0.6 Tanimoto similarity are returned.</p>
    </sec>
    <sec id="Sec8">
      <title>Compound summary page and analogs</title>
      <p id="Par39">As shown in the database schema in Fig. <xref rid="Fig1" ref-type="fig">1</xref>, updates featuring the molecular mass and additional compound identification parameters were implemented within the compounds table. Further, a new table was created to link analogs to the respective compounds. Each compound now has the option to view and download commercially available analogs. A total of 380,206 commercially available analogs were added from the Mcule [<xref ref-type="bibr" rid="CR37">37</xref>] and MolPort [<xref ref-type="bibr" rid="CR38">38</xref>] databases (at the time of writing). A user can see a list of analogs ordered by similarity score for any compound in SANCDB. Each analog links to its respective entry on the vendor’s website.<fig id="Fig1"><label>Fig. 1</label><caption><p>Database schema detailing additions to the existing SANCDB database, compound summary and analog pages. <bold>a</bold> Basic compound information (Name, Formula, SMILES…). <bold>b</bold> Allows users to view 2D and 3D depictions of the compound. <bold>c</bold> Structure download options and navigation to page listing commercially available analogs. <bold>d</bold> References, classifications, other names, sources organisms and uses. Analogs are updated monthly using an automated pipeline to access external database APIs, calculate similarity scores and insert into the local SQL database</p></caption><graphic xlink:href="13321_2021_514_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par40">From the compound summary page, for each compound there are also links to ChEMBL, DrugBank, PubChem, and ZINC databases, if available. Data points for molecular mass and, when available, a link to ChemSpider have been added to the interface. Standardized compound classifications according to ClassyFire, are displayed in addition to all existing classifications. Previously, compound structures for MOL2, PDB, minimized PDB, SDF and SMILES were available. Subsequently, Maestro and PDBQT files have been added to these options for existing and new compounds.</p>
    </sec>
    <sec id="Sec9">
      <title>Database content</title>
      <p id="Par41">The database initially contained 600 compounds updated here to 1012 compounds from 359 literature references comprising mainly journal articles. Cumulatively, compounds had been isolated from 321 sources, distributed among five biological kingdoms (fungi, bacteria, plants etc.), 104 distinct families and 187 genera. The distribution of the sources of compounds according to their families and kingdoms is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>a. Plants represented the majority of the sources counting for 854 compounds (78.3%) followed by animals 219 (20.1%), fungi 9 (0.8%), chromista 6 (0.5%) and finally bacteria with 3 compounds (0.3%). This distribution is similar to some of the NPs databases where plants are the primary sources [<xref ref-type="bibr" rid="CR48">48</xref>]. It is interesting to note the low proportion of compounds, isolated from bacterial and from microbial sources, given that they are major sources of NPs [<xref ref-type="bibr" rid="CR3">3</xref>]. <italic>Streptomyces sp.</italic> with three isoflavones was the only bacteria species source reported in the entire database. <italic>Clathrina aff reticulum</italic>, <italic>Eurotium rubrum</italic>, <italic>Termitomyces microcarpus</italic> and <italic>Fusarium proliferatum</italic> were the only four fungi. Yet, microbes remain sources for major classes of antibiotics [<xref ref-type="bibr" rid="CR3">3</xref>]. This low microbial source proportion was also consistent with other NPs databases [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], and some databases only focus on plants [<xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR66">66</xref>] probably because of their abundance as NP sources. The potential of NPs from microbes in South Africa may be under-explored. A similar observation was made in the source distribution of the Brazilian compound database NuBBE [<xref ref-type="bibr" rid="CR48">48</xref>]. Plants were found to be the major producer of NPs compared to other sources (animals, fungi, bacteria) [<xref ref-type="bibr" rid="CR67">67</xref>]. This may be explained by plant uses being more documented in traditional medicines and having easier accessibility than other sources.<fig id="Fig2"><label>Fig. 2</label><caption><p><bold>a</bold> Compound sources distribution. Sources’ species were mapped to their kingdoms, families and genera using pygbif [<xref ref-type="bibr" rid="CR28">28</xref>]. <bold>b</bold> Most reported species within SANCDB. Only the top 10 species producing highest numbers of NPs are reported</p></caption><graphic xlink:href="13321_2021_514_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par42">Regarding families, Asparagaceae (158–14.48%), Asteraceae (112–10.27%), Lamiaceae (68–6.23%), Fabaceae (67–6.14%) and Amaryllidaceae (53–4.86%) were the top family sources. Regarding genera, <italic>Ornithogalum</italic> (62–5.7%), <italic>Senecio</italic> (58–5.3%), <italic>Eucomis</italic> (39–3.6%), <italic>Salvia</italic> (39–3.6%) and <italic>Plocamium</italic> (38–3.5%) were the top ones.</p>
      <p id="Par43">The top five species with the highest number of isolated compounds were <italic>Senecio pterophorus</italic> (34–3.1%), <italic>Ornithogalum thyrsoides</italic> (27–2.4%), <italic>Ornithogalum saundersiae</italic> (23–2.1%), <italic>Plocamium corallorhiza</italic> (20–1.8%) and <italic>Cephalodiscus gilchristi</italic> (19–1.7%) as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>b. <italic>Seneccio pterophorus</italic>, is an Asteraceae producing macrocyclic diester pyrrolizidine alkaloids known to be hepatotoxic, carcinogenic, genotoxic and teratogenic [<xref ref-type="bibr" rid="CR68">68</xref>]. Two species of Ornithogalum plant from the Asparagaceae family: <italic>thyrsoides</italic> (27 compounds) and <italic>saundersiae</italic> (23 compounds) were the second and third sources with the highest number of isolated compounds, respectively. The <italic>thyrsoides</italic> species is widespread in South Africa, Western Cape and known for its cytotoxicity against HL-60 human promyelocytic leukemia cells [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. <italic>Ornithogalum saundersiae</italic> is an ornamental flower from Mpumalanga, KwaZulu-Natal, and Swaziland, toxic to cattle [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. Also known as the tube worm [<xref ref-type="bibr" rid="CR73">73</xref>], <italic>Cephalodiscus gilchristi</italic> is a cephalodiscidae containing highly potent alkaloids against lymphocytic leukemia [<xref ref-type="bibr" rid="CR74">74</xref>]. This marine invertebrate also produces cephalostatin 1, a potent cell growth-inhibiting compound [<xref ref-type="bibr" rid="CR73">73</xref>]. Finally, <italic>Plocamium corallorhiza</italic> is a red algae in the family Plocamiaceae, abundant in South Africa known for its halogenated monoterpenes [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. A common characteristic among these top sources is that they are naturally widespread. Thus, they may be more accessible for compound isolation and extraction studies and the source of more compounds as a result. Information in the database may contribute to biodiversity conservation. Indeed, the above information may contribute to finding NPs source hotspots that conservation efforts may prioritize. None of these species was found in the South African National Biodiversity Institute (SANBI) list of endangered species [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
    </sec>
    <sec id="Sec10">
      <title>Compounds classification</title>
      <p id="Par44">NPs classification is useful to assess their diversity, and can be done via different schemes [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Here, ClassyFire, which performs a hierarchical classification using structural patterns into kingdoms, superclasses, classes and subclasses, was utilized [<xref ref-type="bibr" rid="CR20">20</xref>]. We noted 11 superclasses out of the 26 ClassyFire organic compound superclasses; 77 classes out of 764 ClassyFire classes [<xref ref-type="bibr" rid="CR35">35</xref>]; and 124 subclasses. These numbers indicate database diversity, and therefore potentiality for a variety of biological activities. The distribution of compounds superclasses is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, classes in Fig. <xref rid="Fig3" ref-type="fig">3</xref>b and molecular frameworks in Fig. <xref rid="Fig3" ref-type="fig">3</xref>c. Top compound classes were the phenol lipids (251–24.8%), the steroids and steroid derivatives (141–13.9%), the flavonoids (71–7%), the organooxygen compounds (50–4.9%) and the homoisoflavonoids (41–4.1%).<fig id="Fig3"><label>Fig. 3</label><caption><p>Stacked bar charts of the compound classifications. <bold>a</bold> SANCDB compounds superclasses. <bold>b</bold> SANCDB compounds classes. <bold>c</bold> SANCDB molecular frameworks. Classifications were obtained from ClassyFire</p></caption><graphic xlink:href="13321_2021_514_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par45">Comparatively, SANCDB has a similar distribution to other compound databases. The Integrated Ethiopian Traditional Herbal Medicine and Phytochemicals Database (ETM-DB) [<xref ref-type="bibr" rid="CR79">79</xref>] compounds classification was also done using ClassyFire, and shares the same top three superclasses. ETM-DB with 3930 compounds has 22 superclasses and 200 classes. The 500 Pan-African Natural Products Library (p-ANAPL) compounds are distributed across 30 classes [<xref ref-type="bibr" rid="CR80">80</xref>] while the Nuclei of Bioassays, Ecophysiology and Biosynthesis of Natural Products Database (NuBBE) database has 14 classes with 2147 compounds [<xref ref-type="bibr" rid="CR48">48</xref>]. NuBBE and p-ANAPL use however a different classification scheme. SANCDB contains 13.93% of steroids and derivatives, and was previously shown to have the highest rates of steroids compared to other NPs databases [<xref ref-type="bibr" rid="CR81">81</xref>].</p>
      <p id="Par46">The database was rich in polycyclic compounds in Fig. <xref rid="Fig3" ref-type="fig">3</xref>c. Indeed, the molecular framework distribution showed that only 59 (5.8%) of the compounds were acyclic. Nine distinct types of molecular frameworks were found in SANCDB. The most common frameworks were the aromatic heteropolycyclic (416–41.1%), the aliphatic heteropolycyclic (232–22.9%) and the aliphatic homopolycyclic (115–11.4%). Molecular framework is similar to the concept of scaffold [<xref ref-type="bibr" rid="CR44">44</xref>] and describes compounds according to their aliphaticity/aromaticity, ring count, and the diversity of atom types [<xref ref-type="bibr" rid="CR35">35</xref>]. It is an important feature to assess compounds libraries' diversity in screening campaigns [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
    </sec>
    <sec id="Sec11">
      <title>Compounds activities</title>
      <p id="Par47">From the source reference, where significant biological activity of isolated compounds was determined, the information was recorded and standardized to avoid duplication. The distribution of biological activities for the 318 compounds showed anticancer (158–31.6%), antibacterial (61–12.2%), AChE inhibitor (38–7.6%), antimalarial, (34–6.8%) and antiproliferative (20–4.0%) as most common activities (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). We noted 59 distinct activity types. Some compounds showed a variety of activities (&gt; 6 different activities): Combretastatin A-1, Ouabain, Acovenoside A, Isoorientin and Quercetin. They were also found to be associated with at least 15 predicted targets in ChEMBL [<xref ref-type="bibr" rid="CR31">31</xref>] with 90% confidence. They can be a good starting point for multi-target inhibitors. It is noteworthy that activities assignment was not standardized. Recorded activities could be at the molecular, cellular, tissue or disease level. Also, recording of activities was limited to only the reference in the database. Furthermore, only compounds showing a significant level of activity were recorded, limiting the number of assigned biological activities to 318 out of the 1012 in the database.<fig id="Fig4"><label>Fig. 4</label><caption><p>SANCDB compounds biological activities. A donut chart showing the distribution of various biological activities of a total of 318 compounds which have documented use in their references in SANCDB. The top 10 activities classes are shown while the remaining ones are grouped in the others category. The biological activities of the remaining compounds in the database is yet to be reported</p></caption><graphic xlink:href="13321_2021_514_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec12">
      <title>Commercially available analogs</title>
      <p id="Par48">A first evaluation of SANCDB NPs availability showed that only about 30% of SANCDB was readily purchasable. 316 were obtainable on MolPort [<xref ref-type="bibr" rid="CR38">38</xref>] while 327 on Mcule [<xref ref-type="bibr" rid="CR37">37</xref>]. A previous assessment of NPs commercial availability (in the ZINC subset of readily purchasable compounds) showed that only 10% were purchasable [<xref ref-type="bibr" rid="CR3">3</xref>]. In general, NPs are insufficiently covered in commercial databases [<xref ref-type="bibr" rid="CR3">3</xref>]. Additionally, 118 SANCDB compounds had synthetic accessibility [<xref ref-type="bibr" rid="CR82">82</xref>] score greater than six (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1). They may thus pose synthetic challenges [<xref ref-type="bibr" rid="CR82">82</xref>].</p>
      <p id="Par49">In the updated version of SANCDB, a total of 380,206 unique commercially available analogs were added with an average of 1487 analogs per compound (at the time of writing). 232,747 analogs were retrieved from Mcule and 141,320 from Molport. Each compound analogs’ SMILES and Tanimoto similarity scores are available for download. The downloaded Molport [<xref ref-type="bibr" rid="CR38">38</xref>] and Mcule [<xref ref-type="bibr" rid="CR37">37</xref>] databases contained 7,597,214 and 9,884,200 compounds, respectively in October 2019. The distribution of the number of analogs per compound is shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>. Frequencies ranged from 42,224 to zero analogs. SANC00428, SANC00815, SANC00656, SANC00967 and SANC00425 have the highest number of analogs with 42,224, 29,045, 27,823, 26,638, 24,993 analogs respectively. These compounds have low molecular weight (MW). All compounds with more than 10,000 analogs had a MW below 300 Da. However, there was no correlation between the number of analogs and the MW with a negligible Pearson correlation of -0.09 (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figs. S2 and S3).<fig id="Fig5"><label>Fig. 5</label><caption><p>Number of analogs per SANCDB compound. Compound are ordered by their number of analogs (lowest to highest, left to right). Labels on the cells are the compounds IDs. For visibility purposes, the heatmap vmax is set to 6000. Yet some compounds have more than 6000 analogs (indicated by the arrow on the color key). IDs without analogs are in bold. Text color (compounds IDs) varies from white to black for readability. The color gradient represents the count of analogs</p></caption><graphic xlink:href="13321_2021_514_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par50">No analog was found for 70 compounds using a Tanimoto similarity coefficient threshold as low as 0.6. SciFinder [<xref ref-type="bibr" rid="CR27">27</xref>] database was used to manually retrieve analogs for these compounds. As SciFinder [<xref ref-type="bibr" rid="CR27">27</xref>] search was per similarity interval (e.g. 0.75–0.79 similarity interval), only the first interval having analogs, starting from the highest, was considered. The number of analogs for these compounds ranged from one to 29 with 23 compounds having only one analog [<xref ref-type="bibr" rid="CR27">27</xref>]. The number of analogs per compounds and their respective similarity thresholds are available in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1. Also, only 43% (442) of the compounds had more than 1000 analogs in Molport [<xref ref-type="bibr" rid="CR38">38</xref>] and Mcule [<xref ref-type="bibr" rid="CR37">37</xref>] datasets. This indicates a low coverage of NPs availability considering the size of the datasets used (Molport and Mcule with 7,597,214 and 9,884,200 respectively) and the low Tanimoto similarity coefficient cutoff used (0.6).</p>
      <p id="Par51">Analogs covered SANCDB chemical space regions (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). SANCDB compounds formed a cluster overlapped with analogs which extend by decreasing similarity score. Analogs with similarity values in the range (0.6, 0.7) were the most isolated. Some SANCDB compounds without analogs occupied a small isolated cluster (zoomed region of the plot). Further analysis showed that they corresponded to compounds with zero analogs. The t-SNE visualization showed a less dense cloud, thus indicating further separation between compounds (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4).<fig id="Fig6"><label>Fig. 6</label><caption><p>PCA visualization of SANCDB and analogs chemical space. Compounds (n = 375,061) are represented in dots. SANCDB (violet, n = 1012). Analogs are in bins of similarity values: (0.6,0.7) blue, n = 266,147; (0.7,0.8) orange, n = 69,336; (0.8,0.9) green, n = 24,679; [0.9,1] red, n = 13,887. As an analog may have different similarity scores with different SANCDB compounds, the maximum similarity score was chosen for each analog. The first two components explain 81% of the variance (PC1 (66%), PC1 (15%))</p></caption><graphic xlink:href="13321_2021_514_Fig6_HTML" id="MO6"/></fig></p>
      <p id="Par52">SANCDB analogs can expand initial drug discovery projects. Analog information is important during hit optimization in drug discovery process. Screening hits identified from SANCDB can be further optimized through their analogs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Additionally, more potent analogs of the potential allosteric modulators identified in SANCDB [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR84">84</xref>] may further enhance allosteric modulation of these compounds on their targets.</p>
    </sec>
    <sec id="Sec13">
      <title>Scaffolds and compounds subsets</title>
      <p id="Par53">SANCDB compounds were analyzed in terms of their scaffolds and with regard to different subsets of chemical compounds relevant to drug discovery. NPs scaffolds are of interest as they are rich in sp<sup>3</sup>-configured centers while synthetic scaffolds are generally flatter [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. They also often serve as the basis for synthetic modifications of drug-like compounds [<xref ref-type="bibr" rid="CR65">65</xref>]. Scaffold diversity is ideal for screening libraries as virtual screening also aims to find new scaffolds [<xref ref-type="bibr" rid="CR66">66</xref>].</p>
      <p id="Par54">The molecule cloud visualization in Fig. <xref rid="Fig7" ref-type="fig">7</xref> highlights top-ranked scaffolds. It also helps assess the diversity of scaffolds and their structural features, allowing the reader a rapid overview of the most common scaffolds [<xref ref-type="bibr" rid="CR47">47</xref>]. However, a drawback may be the less visible of the less common scaffolds which may still be of interest. All scaffolds and their count are presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2.<fig id="Fig7"><label>Fig. 7</label><caption><p>Molecule cloud of SANCDB scaffolds. Structure sizes indicate scaffold frequencies. The benzene ring is a special case, being the most frequent scaffold in all large data sets [<xref ref-type="bibr" rid="CR48">48</xref>]. Therefore, it is not displayed. A figure with the most common scaffolds and their frequencies is presented in Fig. S5</p></caption><graphic xlink:href="13321_2021_514_Fig7_HTML" id="MO7"/></fig></p>
      <p id="Par55">In SANCDB, about half of the compounds presented a unique scaffold. Indeed, 501 unique scaffolds were identified from the 1012 compounds, indicating their diversity. 59 compounds did not present a scaffold as they were purely aliphatic. Scaffold frequencies followed a “long tail” distribution (see Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5) common in compound datasets [<xref ref-type="bibr" rid="CR47">47</xref>]. This shows the high number of singletons, compounds containing a unique scaffold in the entire database, highlighting this latter diversity.</p>
      <p id="Par56">Most common scaffolds were flavonoids, already known to be common in NP datasets [<xref ref-type="bibr" rid="CR44">44</xref>]. Interestingly, they were only the third most represented in the distribution of compound classes in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. This may be related to a structural diversity in the first two categories compared to flavonoid which may be more homogeneous. Structures of the top 10 scaffolds are represented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6. The chromane 3-Benzylchroman-4-one was the most common scaffold with 30 compounds. Its structure presents a bicycle consisting of a 3,4-dihydro-1-benzopyran, with a ketone group which is a structural alert. Structural alerts are high reactive groups which may cause toxicity [<xref ref-type="bibr" rid="CR86">86</xref>]. The compound is known for human monoamine oxidase B inhibition [<xref ref-type="bibr" rid="CR87">87</xref>]. Chromane scaffolds are promiscuous in NPs [<xref ref-type="bibr" rid="CR67">67</xref>] and known for their anticancer activity [<xref ref-type="bibr" rid="CR88">88</xref>] which may also be related with the database richness in anticancer compounds in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. The second most abundant was flavone found in 21 compounds. Its prodrug aminoflavone reached phase 2 clinical trials for breast cancer treatment [<xref ref-type="bibr" rid="CR87">87</xref>]. The related compound in the database may present similar activity. Finally, flavanone was the third most common scaffold with 14 compounds. This scaffold also presented a ketone group as a structural alert.</p>
      <p id="Par57">Over half of the database was drug-like or extended drug-like compounds, shown in Fig. <xref rid="Fig8" ref-type="fig">8</xref>. We noted a minor difference (41 compounds) between the drug-like and extended drug-like compounds, with the latter having only two more conditions to the drug-like category. PPI-like and fragments-like subsets represent the most stringent conditions for the database compounds, hence showing the least number of compounds. NP datasets may have a low proportion of fragments due to their polycyclic nature. As shown by the compound classification, SANCDB was rich in polycyclic compounds (~ 75% of the compounds see Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). Thus, a low proportion of fragments is expected. PPI-like compounds (MW &gt; 400 and logP &gt; 4) represented the smallest set with only 78 compounds. This contrasts with the high proportion of polycyclic compounds in the database. Given these low proportions of fragment-like and PPI-like compounds, the database may not be suitable for fragment-based drug discovery or protein–protein inhibition.<fig id="Fig8"><label>Fig. 8</label><caption><p>Proportions of compounds in each subset (drug-like, extended drug-like, fragment-like, lead-like, PPI-like). The count of each subset and their related proportions on the x-axis are reported. The green area indicates compounds fitting into that category. In the PAINS group, it indicates compound free of PAINS patterns</p></caption><graphic xlink:href="13321_2021_514_Fig8_HTML" id="MO8"/></fig></p>
      <p id="Par58">These proportions were similar to those observed in many other NPs databases with drug-like and extended drug-like being more than 50% while PPI-like, fragments-like and PAINS have low proportions [<xref ref-type="bibr" rid="CR45">45</xref>].</p>
      <p id="Par59">These subsets fit different contexts in drug discovery. For example, fragments can easily be found in early stage screening to identify potent chemotypes for latter optimization. PPI-like are ideal candidates to block protein–protein interaction. The distribution of the different subsets can also be a good indicator of the ideal context for a dataset. For example, for a database enriched in fragments, fragment-based drug discovery approaches might be ideal. Small molecule databases for screening such as ZINC [<xref ref-type="bibr" rid="CR33">33</xref>] are often subdivided into subsets. PAINS patterns are used to filter out frequent hitters in screening [<xref ref-type="bibr" rid="CR89">89</xref>]. Hence, the various SANCDB subsets can be used to establish custom-made virtual screening experiments based on user’s specific demands.</p>
    </sec>
  </sec>
  <sec id="Sec14">
    <title>Conclusions</title>
    <p id="Par60">NPs remain an integral component of the drug discovery process. Hitherto, a large proportion of approved drugs have been derived from NPs [<xref ref-type="bibr" rid="CR5">5</xref>]. This has inspired the establishment of numerous databases which contain diverse chemical classes of NPs to facilitate bioprospecting of important leads for biomedical and chemical research [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Since the establishment of SANCDB in 2015, its usage as a source of data for both in silico screening and machine learning has been on the rise. Thus, to maintain its relevance, the current work aimed to update the database with additional compounds isolated from South African natural resources, as well as to add new functionalities aimed at providing a larger chemical space for hit exploration. To this end, the updated fully referenced relational database contains more than 1000 unique compounds from South Africa. A classification and scaffold analysis showed a diverse chemical representation with 501 unique NP scaffolds. The chemical diversity of a database is an indicator of how useful it can be for hit identification [<xref ref-type="bibr" rid="CR25">25</xref>]. The database dataset is freely accessible and is downloadable in different chemical formats including ready to dock ones using either AutoDock [<xref ref-type="bibr" rid="CR58">58</xref>] or Maestro from Schrödinger [<xref ref-type="bibr" rid="CR37">37</xref>]. In consideration of the universally acknowledged limitations of NPs as a result of their complex structural organization, the current update also includes the incorporation of readily available analogs from two main commercial chemical databases (MolPort [<xref ref-type="bibr" rid="CR38">38</xref>] and Mcule [<xref ref-type="bibr" rid="CR37">37</xref>]). In comparison to other existing NP databases, this feature is present only in SANCDB and will provide users with a larger chemical library of compounds for both chemoinformatic and bioscreening studies. The analogs from the different databases are constantly updated via an automated pipeline making it more reliable. Analogs have been linked to their sources on Mcule [<xref ref-type="bibr" rid="CR37">37</xref>] and MolPort [<xref ref-type="bibr" rid="CR38">38</xref>], allowing users to obtain compounds for in vitro screening seamlessly.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec15">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13321_2021_514_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1:</bold><bold>Fig S1.</bold> Distribution of SAscore for SANCDB compounds. X-axis represents SAscores and y-axis quantifies the corresponding probability densities. <bold>Fig. S2.</bold> Scatter plot of compounds molecular weight (MW) versus analogs count. X-axis and y-axis correspond to MW (Dalton) and the number of analogs respectively. <bold>Fig. S3.</bold> Scatter plot of compounds molecular weight (MW) versus analogs count. <bold>Fig. S4.</bold> t-SNE visualization of SANCDB and analogs chemical space. <bold>Fig. S5.</bold> Histogram and kernel density distribution of the scaffolds count. <bold>Fig. S6.</bold> Top 10 SANCDB scaffolds structures and their counts. <bold>Table S1.</bold> SANCDB analogs from Sci-finder for compounds without analogs on Mcule and Molport chemical databases. <bold>Table S2.</bold> A summary of all scaffold structures in SANCDB database.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>API</term>
        <def>
          <p id="Par4">Application Programming Interface</p>
        </def>
      </def-item>
      <def-item>
        <term>AChE</term>
        <def>
          <p id="Par5">Acetylcholinesterase</p>
        </def>
      </def-item>
      <def-item>
        <term>CAS</term>
        <def>
          <p id="Par6">Chemical Abstracts Service</p>
        </def>
      </def-item>
      <def-item>
        <term>DOI</term>
        <def>
          <p id="Par7">Digital Object Identifier</p>
        </def>
      </def-item>
      <def-item>
        <term>ETM-DB</term>
        <def>
          <p id="Par8">Integrated Ethiopian Traditional Herbal Medicine and Phytochemicals Database</p>
        </def>
      </def-item>
      <def-item>
        <term>GBIF</term>
        <def>
          <p id="Par9">Global Biodiversity Information Facility</p>
        </def>
      </def-item>
      <def-item>
        <term>MMFF94</term>
        <def>
          <p id="Par10">Merck Molecular Force Field</p>
        </def>
      </def-item>
      <def-item>
        <term>MQN</term>
        <def>
          <p id="Par11">Molecular Quantum Numbers</p>
        </def>
      </def-item>
      <def-item>
        <term>MW</term>
        <def>
          <p id="Par12">Molecular weight</p>
        </def>
      </def-item>
      <def-item>
        <term>NaPLeS</term>
        <def>
          <p id="Par13">Natural products likeness scorer</p>
        </def>
      </def-item>
      <def-item>
        <term>NP</term>
        <def>
          <p id="Par14">Natural Product</p>
        </def>
      </def-item>
      <def-item>
        <term>NPASS</term>
        <def>
          <p id="Par15">Natural Product Activity and Species Source</p>
        </def>
      </def-item>
      <def-item>
        <term>nHA</term>
        <def>
          <p id="Par16">Number of hydrogen bond acceptor</p>
        </def>
      </def-item>
      <def-item>
        <term>nHD</term>
        <def>
          <p id="Par17">Number of hydrogen bond donor</p>
        </def>
      </def-item>
      <def-item>
        <term>nRing</term>
        <def>
          <p id="Par18">Number of rings</p>
        </def>
      </def-item>
      <def-item>
        <term>nRot</term>
        <def>
          <p id="Par19">Number of rotatable bonds</p>
        </def>
      </def-item>
      <def-item>
        <term>NuBBE</term>
        <def>
          <p id="Par20">Nuclei of Bioassays, Ecophysiology and Biosynthesis of Natural Products Database</p>
        </def>
      </def-item>
      <def-item>
        <term>p-ANAPL</term>
        <def>
          <p id="Par21">Pan-African Natural Products Library</p>
        </def>
      </def-item>
      <def-item>
        <term>PPI-like</term>
        <def>
          <p id="Par22">Protein–protein inhibitor like</p>
        </def>
      </def-item>
      <def-item>
        <term>RUBi</term>
        <def>
          <p id="Par23">Research Unit in Bioinformatics</p>
        </def>
      </def-item>
      <def-item>
        <term>SANBI</term>
        <def>
          <p id="Par24">South African National Biodiversity Institute</p>
        </def>
      </def-item>
      <def-item>
        <term>SANCDB</term>
        <def>
          <p id="Par25">South African natural compound database</p>
        </def>
      </def-item>
      <def-item>
        <term>TPSA</term>
        <def>
          <p id="Par26">Total Polar Surface Area</p>
        </def>
      </def-item>
      <def-item>
        <term>t-SNE</term>
        <def>
          <p id="Par27">T-Distributed Stochastic Neighbor Embedding</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Authors acknowledge use of Centre for High Performance Computing (CHPC), South Africa.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors' contributions</title>
    <p>Conceptualization ÖTB; methodology, BND, MG, TMM, KL and ÖTB; validation TMM, KL and ÖTB; formal analysis, BND, MG, TMM, KL and ÖTB; investigation, BND, MG, TMM; resources, KL and ÖTB; data curation, BND, MG, TMM; writing—original draft preparation, BND, MG, TMM; writing—review and editing, BND, MG, TMM, KL and ÖTB; visualization, BND, MG, TMM, KL and ÖTB; supervision, KL and ÖTB; project administration, KL, and ÖTB; funding acquisition ÖTB. All authors have read and agreed to the published version of the manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported through the DELTAS Africa Initiative [grant 107740/Z/15/Z]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DELGEME grant 107740/Z/15/Z] and the UK government. MG is funded as a software developer by H3ABioNet, which is supported by the National Institutes of Health Common Fund grant number U24HG006941. TMM is funded as a postdoctoral fellow by Grand Challenges Africa programme [GCA/DD/rnd3/023]. Grand Challenges Africa is a programme of the African Academy of Sciences (AAS) implemented through the Alliance for Accelerating Excellence in Science in Africa (AESA) platform, an initiative of the AAS and the African Union Development Agency (AUDA-NEPAD). GC Africa is supported by the Bill &amp; Melinda Gates Foundation (BMGF), Swedish International Development Cooperation Agency (SIDA), German Federal Ministry of Education and Research (BMBF), Medicines for Malaria Venture (MMV), and Drug Discovery and Development Centre of University of Cape Town (H3D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the funders.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All data generated or analysed during this study are included in this published article. Supplementary information accompanies this article. SANCDB is freely available at <ext-link ext-link-type="uri" xlink:href="https://sancdb.rubi.ru.ac.za/">https://sancdb.rubi.ru.ac.za/</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par61">The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorokina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Review on natural products databases: where to find data in 2020</article-title>
        <source>J Cheminform</source>
        <year>2020</year>
        <volume>12</volume>
        <fpage>1</fpage>
        <lpage>51</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-020-00424-9</pub-id>
        <pub-id pub-id-type="pmid">33430988</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mishra</surname>
            <given-names>BB</given-names>
          </name>
          <name>
            <surname>Tiwari</surname>
            <given-names>VK</given-names>
          </name>
        </person-group>
        <article-title>Natural products: an evolving role in future drug discovery</article-title>
        <source>Eur J Med Chem</source>
        <year>2011</year>
        <volume>46</volume>
        <fpage>4769</fpage>
        <lpage>4807</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.07.057</pub-id>
        <?supplied-pmid 21889825?>
        <pub-id pub-id-type="pmid">21889825</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>De Bruyn</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Kirchmair</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Data resources for the computer-guided discovery of bioactive natural products</article-title>
        <source>J Chem Inf Model</source>
        <year>2017</year>
        <volume>57</volume>
        <fpage>2099</fpage>
        <lpage>2111</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00341</pub-id>
        <?supplied-pmid 28853576?>
        <pub-id pub-id-type="pmid">28853576</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Newman</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Cragg</surname>
            <given-names>GM</given-names>
          </name>
        </person-group>
        <article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title>
        <source>J Nat Prod</source>
        <year>2020</year>
        <volume>83</volume>
        <fpage>770</fpage>
        <lpage>803</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id>
        <?supplied-pmid 32162523?>
        <pub-id pub-id-type="pmid">32162523</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Calixto</surname>
            <given-names>JB</given-names>
          </name>
        </person-group>
        <article-title>The role of natural products in modern drug discovery</article-title>
        <source>An Acad Bras Cienc</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1590/0001-3765201920190105</pub-id>
        <?supplied-pmid 31166478?>
        <pub-id pub-id-type="pmid">31166478</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hatherley</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Musyoka</surname>
            <given-names>TM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SANCDB: A South African natural compound database</article-title>
        <source>J Cheminform</source>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.1186/s13321-015-0080-8</pub-id>
        <?supplied-pmid 26097510?>
        <pub-id pub-id-type="pmid">26097510</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorokina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Naples: a natural products likeness scorer—web application and database</article-title>
        <source>J Cheminform</source>
        <year>2019</year>
        <volume>11</volume>
        <fpage>1</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-019-0378-z</pub-id>
        <pub-id pub-id-type="pmid">30604073</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cockroft</surname>
            <given-names>NT</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>JR</given-names>
          </name>
        </person-group>
        <article-title>STarFish: a stacked ensemble target fishing approach and its application to natural products</article-title>
        <source>J Chem Inf Model</source>
        <year>2019</year>
        <volume>59</volume>
        <fpage>4906</fpage>
        <lpage>4920</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00489</pub-id>
        <?supplied-pmid 31589422?>
        <pub-id pub-id-type="pmid">31589422</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Stork</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hirte</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kirchmair</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>NP-Scout: machine learning approach for the quantification and visualization of the natural product-likeness of small molecules</article-title>
        <source>Biomolecules</source>
        <year>2019</year>
        <volume>9</volume>
        <fpage>43</fpage>
        <pub-id pub-id-type="doi">10.3390/biom9020043</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NPASS: Natural product activity and species source database for natural product research, discovery and tool development</article-title>
        <source>Nucleic Acids Res</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1026</pub-id>
        <?supplied-pmid 29992232?>
        <pub-id pub-id-type="pmid">29992232</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sorokina</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Merseburger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rajan</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>COCONUT online: collection of open natural products database</article-title>
        <source>J Cheminform</source>
        <year>2021</year>
        <volume>13</volume>
        <fpage>2</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-020-00478-9</pub-id>
        <?supplied-pmid 33423696?>
        <pub-id pub-id-type="pmid">33423696</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Veale</surname>
            <given-names>CGL</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Recent highlights in anti-infective medicinal chemistry from South Africa</article-title>
        <source>ChemMedChem</source>
        <year>2020</year>
        <volume>15</volume>
        <fpage>809</fpage>
        <lpage>826</lpage>
        <pub-id pub-id-type="doi">10.1002/cmdc.202000086</pub-id>
        <?supplied-pmid 32149446?>
        <pub-id pub-id-type="pmid">32149446</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Musyoka</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Kanzi</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Lobb</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Ö</given-names>
          </name>
        </person-group>
        <article-title>Structure based docking and molecular dynamic studies of plasmodial cysteine proteases against a south african natural compound and its analogs</article-title>
        <source>Sci Rep</source>
        <year>2016</year>
        <volume>6</volume>
        <fpage>23690</fpage>
        <pub-id pub-id-type="doi">10.1038/srep23690</pub-id>
        <?supplied-pmid 27030511?>
        <pub-id pub-id-type="pmid">27030511</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Penkler</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Atilgan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Ö</given-names>
          </name>
        </person-group>
        <article-title>Allosteric modulation of human hsp90α conformational dynamics</article-title>
        <source>J Chem Inf Model</source>
        <year>2018</year>
        <volume>58</volume>
        <fpage>383</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00630</pub-id>
        <?supplied-pmid 29378140?>
        <pub-id pub-id-type="pmid">29378140</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Amusengeri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Ö</given-names>
          </name>
        </person-group>
        <article-title>Discorhabdin N, a South African natural compound, for Hsp72 and Hsc70 allosteric modulation: combined study of molecular modeling and dynamic residue network analysis</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.3390/molecules24010188</pub-id>
        <?supplied-pmid 30621342?>
        <pub-id pub-id-type="pmid">30621342</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Musyoka</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Özlem</surname>
            <given-names>TB</given-names>
          </name>
        </person-group>
        <article-title>South African abietane diterpenoids and their analogs as potential antimalarials: novel insights from hybrid computational approaches</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>4036</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules24224036</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kimuda</surname>
            <given-names>MP</given-names>
          </name>
          <name>
            <surname>Laming</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hoppe</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>O</given-names>
          </name>
        </person-group>
        <article-title>Identification of novel potential inhibitors of pteridine reductase 1 in <italic>Trypanosoma brucei</italic> via computational structure-based approaches and in vitro inhibition assays</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.3390/molecules24010142</pub-id>
        <?supplied-pmid 30609681?>
        <pub-id pub-id-type="pmid">30609681</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Verma</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Trozzi</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Predicting potential sars-cov-2 drugs-in depth drug database screening using deep neural network framework ssnet, classical virtual screening and docking</article-title>
        <source>Int J Mol Sci</source>
        <year>2021</year>
        <volume>22</volume>
        <fpage>1</fpage>
        <lpage>16</lpage>
        <pub-id pub-id-type="doi">10.3390/ijms22031392</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nyamai</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Ö</given-names>
          </name>
        </person-group>
        <article-title>Identification of selective novel hits against plasmodium falciparum prolyl tRNA synthetase active site and a predicted allosteric site using in silico approaches</article-title>
        <source>Int J Mol Sci</source>
        <year>2020</year>
        <volume>21</volume>
        <fpage>3803</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms21113803</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fantoukh</surname>
            <given-names>OI</given-names>
          </name>
          <name>
            <surname>Dale</surname>
            <given-names>OR</given-names>
          </name>
          <name>
            <surname>Parveen</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Safety assessment of phytochemicals derived from the globalized South African Rooibos Tea (<italic>Aspalathus linearis</italic>) through interaction with CYP, PXR, and P-gp</article-title>
        <source>J Agric Food Chem</source>
        <year>2019</year>
        <volume>67</volume>
        <fpage>4967</fpage>
        <lpage>4975</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jafc.9b00846</pub-id>
        <?supplied-pmid 30955332?>
        <pub-id pub-id-type="pmid">30955332</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Awolola</surname>
            <given-names>GV</given-names>
          </name>
          <name>
            <surname>Sofidiya</surname>
            <given-names>MO</given-names>
          </name>
          <name>
            <surname>Baijnath</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The phytochemistry and gastroprotective activities of the leaves of <italic>Ficus glumosa</italic></article-title>
        <source>South African J Bot</source>
        <year>2019</year>
        <volume>126</volume>
        <fpage>190</fpage>
        <lpage>195</lpage>
        <pub-id pub-id-type="doi">10.1016/j.sajb.2019.01.015</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Engelhardt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Petereit</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lechtenberg</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Qualitative and quantitative phytochemical characterization of <italic>Myrothamnus flabellifolia</italic> Welw</article-title>
        <source>Fitoterapia</source>
        <year>2016</year>
        <volume>114</volume>
        <fpage>69</fpage>
        <lpage>80</lpage>
        <pub-id pub-id-type="doi">10.1016/j.fitote.2016.08.013</pub-id>
        <?supplied-pmid 27575326?>
        <pub-id pub-id-type="pmid">27575326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bernardini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tiezzi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Laghezza Masci</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ovidi</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Natural products for human health: an historical overview of the drug discovery approaches</article-title>
        <source>Nat Prod Res</source>
        <year>2018</year>
        <volume>32</volume>
        <fpage>1926</fpage>
        <lpage>1950</lpage>
        <pub-id pub-id-type="doi">10.1080/14786419.2017.1356838</pub-id>
        <?supplied-pmid 28748726?>
        <pub-id pub-id-type="pmid">28748726</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cragg</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Newman</surname>
            <given-names>DJ</given-names>
          </name>
        </person-group>
        <article-title>Natural products: a continuing source of novel drug leads</article-title>
        <source>Biochim Biophys Acta</source>
        <year>2013</year>
        <volume>1830</volume>
        <fpage>3670</fpage>
        <lpage>3695</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.02.008</pub-id>
        <?supplied-pmid 23428572?>
        <pub-id pub-id-type="pmid">23428572</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garcia-Castro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zimmermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sankar</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Scaffold diversity synthesis and its application in probe and drug discovery</article-title>
        <source>Angew Chemie Int Ed</source>
        <year>2016</year>
        <volume>55</volume>
        <fpage>7586</fpage>
        <lpage>7605</lpage>
        <pub-id pub-id-type="doi">10.1002/anie.201508818</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <mixed-citation publication-type="other">Elsevier (2010) Elsevier Developer Portal. In: Elsevier.com. <ext-link ext-link-type="uri" xlink:href="https://dev.elsevier.com/tecdoc_text_mining.html">https://dev.elsevier.com/tecdoc_text_mining.html</ext-link>. Accessed 11 Jul 2020</mixed-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <mixed-citation publication-type="other">CAS (2015) SciFinder - A CAS Solution. In: Publication. <ext-link ext-link-type="uri" xlink:href="http://www.cas.org/products/scifinder">http://www.cas.org/products/scifinder</ext-link>. Accessed 24 Oct 2015.</mixed-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <mixed-citation publication-type="other">Chamberlain S pygbif 0.4.0 documentation—pygbif 0.4.0 documentation. <ext-link ext-link-type="uri" xlink:href="https://pygbif.readthedocs.io/en/latest/index.html">https://pygbif.readthedocs.io/en/latest/index.html</ext-link>. Accessed 4 Jun 2020</mixed-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <mixed-citation publication-type="other">GBIF. <ext-link ext-link-type="uri" xlink:href="https://www.gbif.org/">https://www.gbif.org/</ext-link>. Accessed 4 Jun 2020</mixed-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <mixed-citation publication-type="other">Swain M (2014) PubChemPy: A way to interact with PubChem in Python</mixed-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mendez</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bento</surname>
            <given-names>AP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ChEMBL: towards direct deposition of bioassay data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D930</fpage>
        <lpage>D940</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id>
        <?supplied-pmid 30398643?>
        <pub-id pub-id-type="pmid">30398643</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lo</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Iynkkaran</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Res</source>
        <year>2017</year>
        <volume>46</volume>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sterling</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Irwin</surname>
            <given-names>JJ</given-names>
          </name>
        </person-group>
        <article-title>ZINC 15—ligand discovery for everyone</article-title>
        <source>J Chem Inf Model</source>
        <year>2015</year>
        <volume>55</volume>
        <fpage>2324</fpage>
        <lpage>2337</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.5b00559</pub-id>
        <?supplied-pmid 26479676?>
        <pub-id pub-id-type="pmid">26479676</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PubChem 2019 update: improved access to chemical data</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <fpage>D1102</fpage>
        <lpage>D1109</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1033</pub-id>
        <?supplied-pmid 30371825?>
        <pub-id pub-id-type="pmid">30371825</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Djoumbou Feunang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Eisner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClassyFire: automated chemical classification with a comprehensive, computable taxonomy</article-title>
        <source>J Cheminform</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1186/s13321-016-0174-y</pub-id>
        <pub-id pub-id-type="pmid">26807156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Release</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <source>1: Maestro</source>
        <year>2017</year>
        <publisher-loc> New York</publisher-loc>
        <publisher-name>Schrödinger LLC</publisher-name>
        <fpage>2017</fpage>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <mixed-citation publication-type="other">Kiss R, Sandor M, Szalai FA (2012) <ext-link ext-link-type="uri" xlink:href="http://Mcule.com">http://Mcule.com</ext-link>: a public web service for drug discovery. J Cheminform. DOI:10.1186/1758-2946-4-s1-p17</mixed-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <mixed-citation publication-type="other">Easy compound ordering service - MolPort. <ext-link ext-link-type="uri" xlink:href="https://www.molport.com/shop/index">https://www.molport.com/shop/index</ext-link>. Accessed 11 Jul 2020</mixed-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O’Boyle</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Banck</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>CA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Open babel: an open chemical toolbox</article-title>
        <source>J Cheminform</source>
        <year>2011</year>
        <volume>3</volume>
        <fpage>33</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>
        <?supplied-pmid 21982300?>
        <pub-id pub-id-type="pmid">21982300</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">Molecular fingerprints and similarity searching—Open Babel v2.3.0 documentation. <ext-link ext-link-type="uri" xlink:href="http://openbabel.org/docs/dev/Features/Fingerprints.html">http://openbabel.org/docs/dev/Features/Fingerprints.html</ext-link>. Accessed 20 Sep 2020</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilón-Jiménez</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Saldívar-González</surname>
            <given-names>FI</given-names>
          </name>
          <name>
            <surname>Díaz-Eufracio</surname>
            <given-names>BI</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>BIOFACQUIM: a Mexican compound database of natural products</article-title>
        <source>Biomolecules</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.3390/biom9010031</pub-id>
        <?supplied-pmid 30658522?>
        <pub-id pub-id-type="pmid">30658522</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kearney</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Zahoránszky-Kőhalmi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Brimacombe</surname>
            <given-names>KR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Canvass: a crowd-sourced, natural product screening library for exploring biological space</article-title>
        <source>ACS Cent Sci</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.26434/CHEMRXIV.7172369.V2</pub-id>
        <?supplied-pmid 30648156?>
        <pub-id pub-id-type="pmid">30648156</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sánchez-Cruz</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pilón-Jiménez</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Functional group and diversity analysis of BIOFACQUIM: a Mexican natural product database</article-title>
        <source>F1000Res</source>
        <year>2020</year>
        <volume>8</volume>
        <fpage>2071</fpage>
        <pub-id pub-id-type="doi">10.12688/f1000research.21540.2</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Guha</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Giulianotti</surname>
            <given-names>MA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository</article-title>
        <source>J Chem Inf Model</source>
        <year>2009</year>
        <volume>49</volume>
        <fpage>1010</fpage>
        <lpage>1024</lpage>
        <pub-id pub-id-type="doi">10.1021/ci800426u</pub-id>
        <?supplied-pmid 19301827?>
        <pub-id pub-id-type="pmid">19301827</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Saldívar-Gonzaíez</surname>
            <given-names>FI</given-names>
          </name>
          <name>
            <surname>Valli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andricopulo</surname>
            <given-names>AD</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Chemical space and diversity of the NuBBE database: a chemoinformatic characterization</article-title>
        <source>J Chem Inf Model</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00619</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <mixed-citation publication-type="other">The Scopy’s documentation—Scopy 1.2.3 documentation. <ext-link ext-link-type="uri" xlink:href="https://scopy.iamkotori.com/index.html">https://scopy.iamkotori.com/index.html</ext-link>. Accessed 10 Aug 2020</mixed-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rohde</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The molecule cloud—compact visualization of large collections of molecules</article-title>
        <source>J Cheminform</source>
        <year>2012</year>
        <volume>4</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-2946-4-12</pub-id>
        <pub-id pub-id-type="pmid">22236646</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pilon</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Valli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dametto</surname>
            <given-names>AC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NuBBEDB: An updated database to uncover chemical and biological information from Brazilian biodiversity</article-title>
        <source>Sci Rep</source>
        <year>2017</year>
        <pub-id pub-id-type="doi">10.1038/s41598-017-07451-x</pub-id>
        <?supplied-pmid 28775335?>
        <pub-id pub-id-type="pmid">28775335</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>KT</given-names>
          </name>
          <name>
            <surname>Blum</surname>
            <given-names>LC</given-names>
          </name>
          <name>
            <surname>Van Deursen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Reymond</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Classification of organic molecules by molecular quantum numbers</article-title>
        <source>ChemMedChem</source>
        <year>2009</year>
        <volume>4</volume>
        <fpage>1803</fpage>
        <lpage>1805</lpage>
        <pub-id pub-id-type="doi">10.1002/cmdc.200900317</pub-id>
        <?supplied-pmid 19774591?>
        <pub-id pub-id-type="pmid">19774591</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <mixed-citation publication-type="other">Landrum G (2016) RDKit: open-source cheminformatics software</mixed-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Van Der Maaten</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hinton</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Visualizing data using t-SNE</article-title>
        <source>J Mach Learn Res</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>2579</fpage>
        <lpage>2625</lpage>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Janssen</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Grimm</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Wijdeven</surname>
            <given-names>MRH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drug discovery maps, a machine learning model that visualizes and predicts kinome−inhibitor interaction landscapes</article-title>
        <source>J Chem Inf Model</source>
        <year>2018</year>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00640</pub-id>
        <?supplied-pmid 30372617?>
        <pub-id pub-id-type="pmid">30372617</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Naveja</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Medina-Franco</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Finding constellations in chemical space through core analysis</article-title>
        <source>Front Chem</source>
        <year>2019</year>
        <volume>7</volume>
        <fpage>510</fpage>
        <pub-id pub-id-type="doi">10.3389/fchem.2019.00510</pub-id>
        <?supplied-pmid 31380353?>
        <pub-id pub-id-type="pmid">31380353</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yosipof</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Guedes</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>García-Sosa</surname>
            <given-names>AT</given-names>
          </name>
        </person-group>
        <article-title>Data mining and machine learning models for predicting drug likeness and their disease or organ category</article-title>
        <source>Front Chem</source>
        <year>2018</year>
        <volume>6</volume>
        <fpage>162</fpage>
        <pub-id pub-id-type="doi">10.3389/fchem.2018.00162</pub-id>
        <?supplied-pmid 29868564?>
        <pub-id pub-id-type="pmid">29868564</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pedregosa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Varoquaux</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Gramfort</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Scikit-learn: Machine learning in Python</article-title>
        <source>J Mach Learn Res</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>2825</fpage>
        <lpage>2830</lpage>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">sklearn.manifold.TSNE—scikit-learn 0.23.1 documentation. <ext-link ext-link-type="uri" xlink:href="https://scikit-learn.org/stable/modules/generated/sklearn.manifold.TSNE.html">https://scikit-learn.org/stable/modules/generated/sklearn.manifold.TSNE.html</ext-link>. Accessed 17 Jul 2020</mixed-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tosco</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Stiefl</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Landrum</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Bringing the MMFF force field to the RDKit: Implementation and validation</article-title>
        <source>J Cheminform</source>
        <year>2014</year>
        <volume>6</volume>
        <fpage>37</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-014-0037-3</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Morris</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Huey</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lindstrom</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title>
        <source>J Comput Chem</source>
        <year>2009</year>
        <volume>30</volume>
        <fpage>2785</fpage>
        <lpage>2791</lpage>
        <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>
        <?supplied-pmid 2760638?>
        <pub-id pub-id-type="pmid">19399780</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <mixed-citation publication-type="other">Kluyver T, Ragan-Kelley B, Pérez F, et al (2016) Jupyter Notebooks-a publishing format for reproducible computational workflows. In: ELPUB. pp 87–90</mixed-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <mixed-citation publication-type="other">McKinney W (2011) pandas: a Foundational python library for data analysis and statistics. Python High Perform Sci Comput 1–9.</mixed-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McKinney</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Data structures for statistical computing in Python</article-title>
        <source>Proc 9th Python Sci Conf</source>
        <year>2010</year>
        <pub-id pub-id-type="doi">10.25080/majora-92bf1922-00a</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <mixed-citation publication-type="other">Brugman S (2019) pandas-profiling: exploratory data analysis for Python</mixed-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Telukunta</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Döring</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NANPDB: a resource for natural products from northern African sources</article-title>
        <source>J Nat Prod</source>
        <year>2017</year>
        <volume>80</volume>
        <fpage>2067</fpage>
        <lpage>2076</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b00283</pub-id>
        <?supplied-pmid 28641017?>
        <pub-id pub-id-type="pmid">28641017</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zofou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Babiaka</surname>
            <given-names>SB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>AfroDb: a select highly potent and diverse natural product library from African medicinal plants</article-title>
        <source>PLoS ONE</source>
        <year>2013</year>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0078085</pub-id>
        <?supplied-pmid 24282507?>
        <pub-id pub-id-type="pmid">24282507</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Onguéné</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Scharfe</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ConMedNP: a natural product library from Central African medicinal plants for drug discovery</article-title>
        <source>RSC Adv</source>
        <year>2014</year>
        <volume>4</volume>
        <fpage>409</fpage>
        <lpage>419</lpage>
        <pub-id pub-id-type="doi">10.1039/c3ra43754j</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mbah</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Mbaze</surname>
            <given-names>LMa</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CamMedNP: Building the Cameroonian 3D structural natural products database for virtual screening</article-title>
        <source>BMC Complement Altern Med</source>
        <year>2013</year>
        <pub-id pub-id-type="doi">10.1186/1472-6882-13-88</pub-id>
        <?supplied-pmid 23802859?>
        <pub-id pub-id-type="pmid">23802859</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schuhmann</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Cheminformatics analysis of natural product scaffolds: comparison of scaffolds produced by animals, plants, fungi and bacteria</article-title>
        <source>Mol Inform</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1002/minf.202000017</pub-id>
        <?supplied-pmid 32203642?>
        <pub-id pub-id-type="pmid">32203642</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Castells</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mulder</surname>
            <given-names>PPJ</given-names>
          </name>
          <name>
            <surname>Pérez-Trujillo</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Diversity of pyrrolizidine alkaloids in native and invasive Senecio pterophorus (Asteraceae): Implications for toxicity</article-title>
        <source>Phytochemistry</source>
        <year>2014</year>
        <volume>108</volume>
        <fpage>137</fpage>
        <lpage>146</lpage>
        <pub-id pub-id-type="doi">10.1016/j.phytochem.2014.09.006</pub-id>
        <?supplied-pmid 25269662?>
        <pub-id pub-id-type="pmid">25269662</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuroda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ori</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mimaki</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Ornithosaponins A-D, four new polyoxygenated steroidal glycosides from the bulbs of Ornithogalum thyrsoides</article-title>
        <source>Steroids</source>
        <year>2006</year>
        <volume>71</volume>
        <fpage>199</fpage>
        <lpage>205</lpage>
        <pub-id pub-id-type="doi">10.1016/j.steroids.2005.10.001</pub-id>
        <?supplied-pmid 16303157?>
        <pub-id pub-id-type="pmid">16303157</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <mixed-citation publication-type="other">Ornithogalum thyrsoides | PlantZAfrica. <ext-link ext-link-type="uri" xlink:href="http://pza.sanbi.org/ornithogalum-thyrsoides">http://pza.sanbi.org/ornithogalum-thyrsoides</ext-link>. Accessed 15 Jun 2020</mixed-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <mixed-citation publication-type="other">Ornithogalum saundersiae | PlantZAfrica. <ext-link ext-link-type="uri" xlink:href="http://pza.sanbi.org/ornithogalum-saundersiae">http://pza.sanbi.org/ornithogalum-saundersiae</ext-link>. Accessed 15 Jun 2020</mixed-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Iguchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kuroda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Naito</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cholestane glycosides from Ornithogalum saundersiae bulbs and the induction of apoptosis in HL-60 cells by OSW-1 through a mitochondrial-independent signaling pathway</article-title>
        <source>J Nat Med</source>
        <year>2019</year>
        <volume>73</volume>
        <fpage>131</fpage>
        <lpage>145</lpage>
        <pub-id pub-id-type="doi">10.1007/s11418-018-1252-4</pub-id>
        <?supplied-pmid 30327993?>
        <pub-id pub-id-type="pmid">30327993</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davies-Coleman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Veale</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Recent advances in drug discovery from South African marine invertebrates</article-title>
        <source>Mar Drugs</source>
        <year>2015</year>
        <volume>13</volume>
        <fpage>6366</fpage>
        <lpage>6383</lpage>
        <pub-id pub-id-type="doi">10.3390/md13106366</pub-id>
        <?supplied-pmid 26473891?>
        <pub-id pub-id-type="pmid">26473891</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pettit</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Kamano</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dufresne</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Isolation and structure of the unusual Indian Ocean Cephalodiscus gilchristi components, cephalostatins 5 and 6</article-title>
        <source>Can J Chem</source>
        <year>1989</year>
        <volume>67</volume>
        <fpage>1509</fpage>
        <lpage>1513</lpage>
        <pub-id pub-id-type="doi">10.1139/v89-231</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Knott</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Mkwananzi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Arendse</surname>
            <given-names>CE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Plocoralides A-C, polyhalogenated monoterpenes from the marine alga <italic>Plocamium corallorhiza</italic></article-title>
        <source>Phytochemistry</source>
        <year>2005</year>
        <volume>66</volume>
        <fpage>1108</fpage>
        <lpage>1112</lpage>
        <pub-id pub-id-type="doi">10.1016/j.phytochem.2005.03.029</pub-id>
        <?supplied-pmid 15924916?>
        <pub-id pub-id-type="pmid">15924916</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mann</surname>
            <given-names>MGA</given-names>
          </name>
          <name>
            <surname>Mkwananzi</surname>
            <given-names>HB</given-names>
          </name>
          <name>
            <surname>Antunes</surname>
            <given-names>EM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Halogenated monoterpene aldehydes from the South African marine alga <italic>Plocamium corallorhiza</italic></article-title>
        <source>J Nat Prod</source>
        <year>2007</year>
        <volume>70</volume>
        <fpage>596</fpage>
        <lpage>599</lpage>
        <pub-id pub-id-type="doi">10.1021/np060547c</pub-id>
        <?supplied-pmid 17343409?>
        <pub-id pub-id-type="pmid">17343409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <mixed-citation publication-type="other">SANBI (2019) Threatened Species Programme | SANBI Red List of South African Plants. In: South African Natl Biodivers Inst <ext-link ext-link-type="uri" xlink:href="http://redlist.sanbi.org/stats.php">http://redlist.sanbi.org/stats.php</ext-link>. Accessed 9 Jul 2020</mixed-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Banerjee</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Erehman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gohlke</surname>
            <given-names>BO</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Super natural II-a database of natural products</article-title>
        <source>Nucleic Acids Res</source>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.1093/nar/gku886</pub-id>
        <?supplied-pmid 26578590?>
        <pub-id pub-id-type="pmid">26578590</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bultum</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Woyessa</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>ETM-DB: integrated Ethiopian traditional herbal medicine and phytochemicals database</article-title>
        <source>BMC Complement Altern Med</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1186/s12906-019-2634-1</pub-id>
        <?supplied-pmid 31412866?>
        <pub-id pub-id-type="pmid">31412866</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ntie-Kang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Amoa Onguéné</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Fotso</surname>
            <given-names>GW</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Virtualizing the p-ANAPL Library: a step towards drug discovery from African medicinal plants</article-title>
        <source>PLoS ONE</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e90655</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0090655</pub-id>
        <?supplied-pmid 24599120?>
        <pub-id pub-id-type="pmid">24599120</pub-id>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Garcia De Lomana</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Friedrich</surname>
            <given-names>NO</given-names>
          </name>
          <name>
            <surname>Kirchmair</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Characterization of the chemical space of known and readily obtainable natural products</article-title>
        <source>J Chem Inf Model</source>
        <year>2018</year>
        <volume>58</volume>
        <fpage>1518</fpage>
        <lpage>1532</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00302</pub-id>
        <?supplied-pmid 30010333?>
        <pub-id pub-id-type="pmid">30010333</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ertl</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schuffenhauer</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions</article-title>
        <source>J Cheminform</source>
        <year>2009</year>
        <volume>1</volume>
        <fpage>8</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-2946-1-8</pub-id>
        <?supplied-pmid 20298526?>
        <pub-id pub-id-type="pmid">20298526</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <mixed-citation publication-type="other">Elkhattabi L, Charoute H, Saile R, Barakat. (2020) A computational approach revealed potential affinity of antiasthmatics against receptor binding domain of 2019n-cov spike glycoprotein. 10.26434/chemrxiv.12115638.v1</mixed-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nyamai</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Tastan Bishop</surname>
            <given-names>Ö</given-names>
          </name>
        </person-group>
        <article-title>Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study</article-title>
        <source>Malar J</source>
        <year>2019</year>
        <volume>18</volume>
        <fpage>1</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1186/s12936-019-2665-6</pub-id>
        <pub-id pub-id-type="pmid">30602373</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mok</surname>
            <given-names>NY</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>On the origins of three-dimensionality in drug-like molecules</article-title>
        <source>Future Med Chem</source>
        <year>2016</year>
        <volume>8</volume>
        <fpage>1753</fpage>
        <lpage>1767</lpage>
        <pub-id pub-id-type="doi">10.4155/fmc-2016-0095</pub-id>
        <?supplied-pmid 27572621?>
        <pub-id pub-id-type="pmid">27572621</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Limban</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nuţă</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Chiriţă</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The use of structural alerts to avoid the toxicity of pharmaceuticals</article-title>
        <source>Toxicol Reports</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>943</fpage>
        <lpage>953</lpage>
        <pub-id pub-id-type="doi">10.1016/j.toxrep.2018.08.017</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <mixed-citation publication-type="other">CHEMBL1766622 Compound Report Card. <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL2079699">https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL2079699</ext-link>. Accessed 3 Sep 2020</mixed-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simon</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Abdul Salam</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Madan Kumar</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives</article-title>
        <source>Bioorganic Med Chem Lett</source>
        <year>2017</year>
        <volume>27</volume>
        <fpage>5284</fpage>
        <lpage>5290</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bmcl.2017.10.026</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baell</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Holloway</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</article-title>
        <source>J Med Chem</source>
        <year>2010</year>
        <volume>53</volume>
        <fpage>2719</fpage>
        <lpage>2740</lpage>
        <pub-id pub-id-type="doi">10.1021/jm901137j</pub-id>
        <?supplied-pmid 20131845?>
        <pub-id pub-id-type="pmid">20131845</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
